<DOC>
	<DOCNO>NCT02376608</DOCNO>
	<brief_summary>The study evaluate relative bioavailability Pronovum PRF-037 Pronovum PRF-041 PronovaPure 150:150 EE EU Eskimo-3 ( 500 mg omega-3 acid triglyceride contain 80 mg EPA 50 mg DHA per gram oil ) healthy subject .</brief_summary>
	<brief_title>Bioavailability Omega-3 Food Supplement Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>male females ethnic origin BMI 18.5 30.0 kg/m2 generally good health sign informed consent male female willing use appropriate contraception prescribe systemic topical medication within 14 day slow release medication consider active within 14 day . omega3 fatty acid fish oil within 2 week dose . nonprescribed systemic topical medication include herbal remedy vitamin/mineral supplement within 7 day medication incl . St.John 's Worth know chronically alter drug absorption/elimination within 30 day Subjects still present clinical study past 3 month recent blood donation drug allergy significant allergic disease allergic hypersensitivity omega3 acid , fish , soya , oleic acid , sesame oil constituent pharma preparation high consumption alcohol high consumption tobacco hepatitis HIV vegetarian earlier participate withdrawn study willing follow dietary restriction frequent occurence migraine attack subject participate accord investigator</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>